2002
DOI: 10.1136/bjo.86.7.809
|View full text |Cite
|
Sign up to set email alerts
|

Comparative experiments for in vivo fibroplasia and biological stability of four porous polymers intended for use in the Seoul-type keratoprosthesis

Abstract: Aims: To evaluate in vivo fibroplasia and biological stability of porous polymers intended for use in the Seoul-type keratoprosthesis (S-KPro). Methods: Four porous polymers (polypropylene, two kinds of polyethylene terephthalate (PE70 and PE50), and polyurethane) were investigated. Discs of polymers were inserted into the corneal stroma of rabbits for a 2 and 5 month period. Corneal oedema and neovascularisation were evaluated. The fibroplasia and collagen deposition were examined under light and transmission… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 13 publications
0
11
0
Order By: Relevance
“…5,6,10 However, as technology moves forward, new-generation 2-piece keratoprostheses may also offer the advantages of improved biointegration, ability to measure intraocular pressure, reduced retroprosthetic membrane formation, and increased visual field. [27][28][29][30][31][32] The FDA has recently approved the AlphaCor intracorneal keratoprosthesis for marketing in the United States. Multicenter clinical trials have been in progress for more than 3 years in Australia and Southeast Asia with outcomes reported in 45 patients.…”
Section: Discussionmentioning
confidence: 99%
“…5,6,10 However, as technology moves forward, new-generation 2-piece keratoprostheses may also offer the advantages of improved biointegration, ability to measure intraocular pressure, reduced retroprosthetic membrane formation, and increased visual field. [27][28][29][30][31][32] The FDA has recently approved the AlphaCor intracorneal keratoprosthesis for marketing in the United States. Multicenter clinical trials have been in progress for more than 3 years in Australia and Southeast Asia with outcomes reported in 45 patients.…”
Section: Discussionmentioning
confidence: 99%
“…However, despite sufficient biocolonization shown in the animal models, skirt exposure was observed in all human eyes. These differences may be due to the effects of the tear film, abnormal fibroblasts in diseased human eyes or enhanced regenerative capabilities of rabbit corneal cells versus those of humans [14,34]. Similar to other devices, the surgical outcome was dependent on the preoperative diagnosis [34].…”
Section: Seoul-type Keratoprosthesismentioning
confidence: 99%
“…No retroprosthetic membranes were observed in the short term, possibly due to the long optic shape, infusion of heparin and/or surface modification of the PMMA with polyethylene glycol to reduce cell adhesion [34,35]. For the first seven human cases, polypropylene was chosen for a skirt material due to improved fibroblast ingrowth and collagen deposition shown in animal studies [14], and better long-term mechanical integrity compared with polyurethane in human eyes [34]. At 25 months' follow-up, the devices were well tolerated in six patients and, despite loosening at the corneal anchorage point, the haptic fixation maintained stability [34].…”
Section: Seoul-type Keratoprosthesismentioning
confidence: 99%
See 1 more Smart Citation
“…The development of a stable keratoprosthesis (KPros) may be a solution towards solving this problem. Several models of Kpros are already in clinical use [1][2][3][4][5] , and 2 models are currently approved by the FDA 2,6 . The stability of Kpros was greatly enhanced by the design of a porous skirt that allowed the integration of host corneal tissue into prosthetic peripheral region 7 .…”
Section: Y Uchino Et Al Amniotic Membrane-pva Corneal Scaffoldmentioning
confidence: 99%